3/2
08:00 am
naut
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
Low
Report
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
2/27
10:58 am
naut
Nautilus Biotechnology (NAUT) had its price target raised by Guggenheim from $2.50 to $4.00. They now have a "buy" rating on the stock.
Low
Report
Nautilus Biotechnology (NAUT) had its price target raised by Guggenheim from $2.50 to $4.00. They now have a "buy" rating on the stock.
2/26
05:59 pm
naut
Nautilus Biotechnology Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Nautilus Biotechnology Q4 Earnings Call Highlights [Yahoo! Finance]
2/26
08:00 am
naut
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results
High
Report
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results
2/24
08:00 am
naut
Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026
Low
Report
Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026
2/19
04:44 pm
naut
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Low
Report
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
2/19
04:05 pm
naut
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
Low
Report
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
2/5
09:27 am
naut
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 [Yahoo! Finance]
Low
Report
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 [Yahoo! Finance]
4/29/2025
08:00 am
naut
nautilus biotechnology, inc.
BEAT
Report
5.9%
nautilus biotechnology, inc.
3/4
07:33 pm
naut
Form SCHEDULE 13D/A Nautilus Biotechnology, Filed by: Mallick Parag
High
Report
Form SCHEDULE 13D/A Nautilus Biotechnology, Filed by: Mallick Parag
3/4
07:33 pm
naut
Form SCHEDULE 13D/A Nautilus Biotechnology, Filed by: Patel Sujal M
High
Report
Form SCHEDULE 13D/A Nautilus Biotechnology, Filed by: Patel Sujal M
3/4
06:37 pm
naut
Form 4 Nautilus Biotechnology, For: Mar 04 Filed by: Patel Sujal M
Medium
Report
Form 4 Nautilus Biotechnology, For: Mar 04 Filed by: Patel Sujal M
3/4
05:32 pm
naut
Form 4 Nautilus Biotechnology, For: Mar 02 Filed by: Mowry Anna
Medium
Report
Form 4 Nautilus Biotechnology, For: Mar 02 Filed by: Mowry Anna
3/4
05:31 pm
naut
Form 4 Nautilus Biotechnology, For: Mar 02 Filed by: Mallick Parag
Medium
Report
Form 4 Nautilus Biotechnology, For: Mar 02 Filed by: Mallick Parag
3/4
05:31 pm
naut
Form 4 Nautilus Biotechnology, For: Mar 02 Filed by: Sankar Subramanian
Medium
Report
Form 4 Nautilus Biotechnology, For: Mar 02 Filed by: Sankar Subramanian
3/4
05:31 pm
naut
Form 4 Nautilus Biotechnology, For: Mar 02 Filed by: Suzuki Kentaro
Medium
Report
Form 4 Nautilus Biotechnology, For: Mar 02 Filed by: Suzuki Kentaro
3/4
05:31 pm
naut
Form 4 Nautilus Biotechnology, For: Mar 02 Filed by: Patel Sujal M
Medium
Report
Form 4 Nautilus Biotechnology, For: Mar 02 Filed by: Patel Sujal M
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register